Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma
✍ Scribed by Robert J. Biggar; Michael Christiansen; Klaus Rostgaard; Karin Ekström Smedby; Hans-Olov Adami; Bengt Glimelius; Henrik Hjalgrim; Mads Melbye
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 145 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Allergy/atopy has been suggested to protect against non‐Hodgkin lymphoma (NHL) and specific IgE levels are decreased in patients with NHL. We speculated that all immunoglobulin subclass levels might be downregulated in NHL and examined levels of IgM, IgD, IgA, IgE, IgG and IgG~4~ in 200 NHL patients and 200 age‐ and sex‐matched controls. Patients with B‐cell NHL of many types had consistently lower median immunoglobulin subclass levels than controls. In every subclass except IgD, about 10–15% of B‐cell NHL patients had absolute levels below the 2.5 percentile of controls. Subclass levels correlated with each other and many patients had more than one significantly low level. Levels were lowest for IgG~4~ and IgE. Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma had especially low total IgE levels. In other B‐cell NHL types, total IgE levels were decreased to a similar extent as other immunoglobulin subclasses. In conclusion, low IgE levels are only part of a more generalized loss of immunoglobulins of all subtypes in a wide variety of B‐cell NHL types. Low immunoglobulin levels appear to be a consequence of B‐cell NHL presence, and we speculate about molecular mechanisms that could reduce all immunoglobulin subclasses in B‐cell NHL. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Background: Previous studies have indicated that some patients with hodgkin disease have an aggressive clinical course. however, their characteristics have not been elucidated. ## Methods: Six patients initially diagnosed as having hodgkin disease with subsequent transformation to cd30 positiv
The causes of death and postmortem findings in patients treated for non-Hodgkin's lymphoma at a single institution over a 13-year period were reviewed. Postmortem examination (70% of the entire sample) revealed evidence of lymphoma in 67 of 80 patients. The most frequent extranodal sites of involvem
## Abstract A retrospective review of the records of 3886 patients with non‐Hodgkin's lymphoma registered at the Princess Margaret Hospital between 1970 and 1985 was undertaken to determine the incidence of second malignant tumours. Three thousand and twenty‐one patients with a minimum documented f